Phio Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PHIO and other ETFs, options, and stocks.About PHIO
Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
CEORobert J. Bitterman
CEORobert J. Bitterman
Employees5
Employees5
HeadquartersMarlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded2011
Founded2011
Employees5
Employees5
PHIO Key Statistics
Market cap11.57M
Market cap11.57M
Price-Earnings ratio-0.48
Price-Earnings ratio-0.48
Dividend yield—
Dividend yield—
Average volume350.01K
Average volume350.01K
High today$1.10
High today$1.10
Low today$1.04
Low today$1.04
Open price$1.09
Open price$1.09
Volume422.61K
Volume422.61K
52 Week high$9.79
52 Week high$9.79
52 Week low$0.9657
52 Week low$0.9657
Stock Snapshot
As of today, Phio Pharmaceutical(PHIO) shares are valued at $1.07. The company's market cap stands at 11.57M, with a P/E ratio of -0.48.
On 2025-12-22, Phio Pharmaceutical(PHIO) stock traded between a low of $1.04 and a high of $1.10. Shares are currently priced at $1.07, which is +2.8% above the low and -2.7% below the high.
The Phio Pharmaceutical(PHIO)'s current trading volume is 422.61K, compared to an average daily volume of 350.01K.
In the last year, Phio Pharmaceutical(PHIO) shares hit a 52-week high of $9.79 and a 52-week low of $0.97.
In the last year, Phio Pharmaceutical(PHIO) shares hit a 52-week high of $9.79 and a 52-week low of $0.97.
People also own
Based on the portfolios of people who own PHIO. This list is generated using Robinhood data, and it’s not a recommendation.